Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

Share Price is delayed by 15 minutes
Get Live Data
50.80    -0.20 (-0.39%)
Bid:
49.95
Ask:
50.30
Spread: 0.35 (0.701%)
Market Cap: £670.89m
IQE Live PriceLast checked at - London Stock Exchange

Intraday IQE Share Chart

IQE plc: Total Voting Rights

31 Oct 2024 07:00

RNS Number : 2770K
IQE PLC
31 October 2024
 

IQE plc

 

 

Total Voting Rights

 

 

Cardiff, UK

31 October 2024

 

 

("IQE" or the "Company")

 

Total Voting Rights

As at 30 September 2024, the Company's issued share capital consisted of 967,220,240 ordinary shares of 1 pence each ("Ordinary Shares"). The Company holds 4,115 Ordinary Shares in treasury. Therefore the total number Ordinary Shares with voting rights in the Company is 967,216,125.

 

Shareholders may use this figure (967,216,125) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Mark Cubitt

Jutta Meier

Amy Barlow

Peel Hunt (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Ben Cryer

Kate Bannatyne

Adam Telling

Deutsche Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

 

Headland Consultancy (Financial PR) + 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

· Smart Connected Devices

· Communications Infrastructure

· Automotive and Industrial

· Aerospace and Security

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRZBLFXZBLBFBL
Date   Source Headline
9th Sep 202510:24 amBUSForm 8.3 - IQE PLC
9th Sep 20259:56 amRNSForm 8.5 (EPT/RI) - IQE plc
9th Sep 20257:00 amRNSIQE plc: Profit Forecast Directors' Confirmations
8th Sep 20255:17 pmRNSIQE plc: Rule 2.9 Announcement
8th Sep 20253:00 pmRNSIQE plc: Holding(s) in Company
8th Sep 20257:00 amRNSIQE plc: Trading Update & Strategic Review Update
5th Sep 20254:00 pmRNSIQE plc: Holding(s) in Company
1st Sep 20254:00 pmRNSIQE plc: Director/PDMR Shareholding
1st Sep 202510:00 amRNSIQE plc: Total Voting Rights
4th Aug 202511:00 amRNSIQE plc: Total Voting Rights - Amended
1st Aug 20258:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSIQE plc: Director/PDMR Shareholding
30th Jun 20254:00 pmRNSIQE plc: Total Voting Rights and Block Admission
30th Jun 20251:00 pmRNSIQE plc: Result of AGM
30th Jun 20257:00 amRNSIQE plc: AGM Notice
16th Jun 20257:00 amRNS-RIQE plc: Completion of joint ULTRARAM™ project
9th Jun 202512:00 pmRNSIQE plc: Holding(s) in Company
9th Jun 20257:00 amRNSIQE plc: Director/PDMR Shareholding
2nd Jun 20254:00 pmRNSIQE plc: Total Voting Rights
27th May 20257:00 amRNSIQE plc: Notice of AGM and Annual Report
13th May 20257:00 amRNSIQE plc: FY 2024 Financial Results
1st May 20257:00 amRNSIQE plc: Notice of Full Year Results
30th Apr 20254:00 pmRNSIQE plc: Total Voting Rights
10th Apr 20257:00 amRNSIQE plc: IQE and X-FAB sign JDA for GaN Power
4th Apr 202512:00 pmRNSIQE plc: Holding(s) in Company
3rd Apr 20257:00 amRNSIQE plc: Holding(s) in Company
1st Apr 20254:00 pmRNSIQE plc: Total Voting Rights
24th Mar 20257:00 amRNSIQE plc: IQE secures Infrared customer commitments
17th Mar 20251:00 pmRNSIQE plc: Holding(s) in Company
14th Mar 202512:00 pmRNSIQE plc: Director/PDMR Shareholding
14th Mar 20257:00 amRNSIQE plc: Closing of CLN Financing
10th Mar 20254:00 pmRNSIQE plc: Results of General Meeting
28th Feb 20254:00 pmRNSIQE plc: Total Voting Rights
12th Feb 20257:00 amRNSIQE plc: Convertible Loan Note Financing
4th Feb 20257:00 amRNSIQE plc: Total Voting Rights
24th Jan 20257:00 amRNSIQE and Quintessent partner on Quantum Dot for AI
23rd Jan 20257:00 amRNSIQE plc: Pre-close Trading Update
2nd Jan 20254:00 pmRNSIQE plc: Total Voting Rights and Block Admission
20th Dec 20247:00 amRNSIQE plc: Board Change
18th Dec 202410:15 amRNSIQE plc: Holding(s) in Company
12th Dec 20247:00 amRNSIQE plc: Holding(s) in Company
4th Dec 20247:00 amRNSIQE plc: Completion of Pennsylvania site sale
2nd Dec 20244:00 pmRNSIQE plc: Total Voting Rights
29th Nov 202411:24 amRNSLong Term Incentive Plan (LTIP) Award
25th Nov 202410:59 amRNSIQE plc: Holding(s) in Company
18th Nov 20247:00 amRNSIQE plc: Trading Update
15th Nov 20247:00 amRNSHolding(s) in Company
14th Nov 20247:00 amRNSIQE plc: Holding(s) in Company
31st Oct 20247:00 amRNSIQE plc: Total Voting Rights
29th Oct 20247:00 amRNSIQE plc: IQE announces departure of CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.